Cymedica Revenue and Competitors
Estimated Revenue & Valuation
- Cymedica's estimated annual revenue is currently $2.5M per year.
- Cymedica's estimated revenue per employee is $251,000
Employee Data
- Cymedica has 10 Employees.
- Cymedica grew their employee count by -41% last year.
Cymedica's People
Name | Title | Email/Phone |
---|
Cymedica Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.8M | 55 | 49% | N/A | N/A |
#2 | $9.8M | 39 | 0% | N/A | N/A |
#3 | $0.5M | 4 | 0% | N/A | N/A |
#4 | $20.3M | 81 | 65% | N/A | N/A |
#5 | $10.8M | 43 | 0% | N/A | N/A |
#6 | $28.1M | 112 | -3% | $83.2M | N/A |
#7 | $6.5M | 26 | 0% | N/A | N/A |
#8 | $8M | 19 | 0% | N/A | N/A |
#9 | $11M | 57 | 6% | N/A | N/A |
#10 | $12M | 48 | 7% | N/A | N/A |
What Is Cymedica?
CyMedica Orthopedics has developed combined therapy-based and digital health technology platform to effectively treat muscles weakened by knee osteoarthritis or surgery. This award-winning digital wearable technology, e-viveâ„¢, is the only FDA cleared, app-based muscle strengthening and patient engagement system uniquely designed to deliver comfortable and individualized muscle stimulation therapy. e-vive provides a platform to improve clinical outcomes while collecting rehabilitation data useful in measuring and promoting patient progress. Muscle weakness is considered one of the most prevalent underlying clinical conditions associated with knee osteoarthritis and the rehabilitation challenges facing patients recovering from knee procedures.
keywords:N/AN/A
Total Funding
10
Number of Employees
$2.5M
Revenue (est)
-41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 10 | 11% | N/A |
#2 | $0.9M | 10 | 11% | N/A |
#3 | $0.9M | 10 | 0% | N/A |
#4 | $0.9M | 10 | 0% | N/A |
#5 | $0.9M | 10 | 0% | N/A |